These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9163560)

  • 1. Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.
    Domino EF; Ni L; Zhang H; Kohno Y; Sasa M
    Eur J Pharmacol; 1997 May; 325(2-3):137-44. PubMed ID: 9163560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trihexyphenidyl interactions with the dopamine D1-selective receptor agonist SKF-82958 and the D2-selective receptor agonist N-0923 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF; Ni L
    J Pharmacol Exp Ther; 1998 Jan; 284(1):307-11. PubMed ID: 9435192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1387-91. PubMed ID: 8099621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pramipexole on contraversive rotation and functional motor impairments in 1-methyl-4-phenyl1,2,3, 6-tetrahydropyridine-induced chronic hemiparkinsonian monkeys.
    Domino EF; Ni L; Zhang H; Kohno Y; Sasa M
    J Pharmacol Exp Ther; 1998 Dec; 287(3):983-7. PubMed ID: 9864283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-dopa and as chronic treatment.
    Irifune M; Nomoto M; Fukuda T
    Eur J Pharmacol; 1994 Oct; 264(2):117-23. PubMed ID: 7851473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of talipexole on contraversive rotation and functional impairment in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF; Ni L; Zhang H; Kohno Y; Sasa M
    Jpn J Pharmacol; 1998 Jul; 77(3):227-33. PubMed ID: 9717770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
    Kohno Y; Fukuzaki K; Kitahara K; Koja T
    Eur J Pharmacol; 1997 Jan; 319(2-3):197-205. PubMed ID: 9042591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats.
    Matsumoto S; Yamada K; Nagashima M; Domae M; Shirakawa K; Furukawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):21-5. PubMed ID: 2571944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of talipexole on motor behavior in normal and MPTP-treated common marmosets.
    Irifune M; Nomoto M; Fukuda T
    Eur J Pharmacol; 1993 Jul; 238(2-3):235-40. PubMed ID: 8104807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
    Kitamura Y; Kohno Y; Nakazawa M; Nomura Y
    Jpn J Pharmacol; 1997 May; 74(1):51-7. PubMed ID: 9195297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective full dopamine D1-like (SKF-82958) and D2-like (N-0923) agonist combination in the MPTP monkey model of hemiparkinsonism.
    Domino EF
    Brain Res Bull; 1997; 43(1):93-5. PubMed ID: 9205801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions.
    Domino EF; Ni L
    Eur J Pharmacol; 2008 Dec; 599(1-3):81-5. PubMed ID: 18851961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys.
    Grondin R; Bédard PJ; Britton DR; Shiosaki K
    Neurology; 1997 Aug; 49(2):421-6. PubMed ID: 9270571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermia induced by the dopamine D1 receptor agonist SK&F38393 in combination with the dopamine D2 receptor agonist talipexole in the rat.
    Nagashima M; Yamada K; Kimura H; Matsumoto S; Furukawa T
    Pharmacol Biochem Behav; 1992 Dec; 43(4):993-7. PubMed ID: 1361996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist.
    Mierau J; Schingnitz G
    Eur J Pharmacol; 1992 May; 215(2-3):161-70. PubMed ID: 1356788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    Akai T; Ozawa M; Yamaguchi M; Mizuta E; Kuno S
    J Pharmacol Exp Ther; 1995 Apr; 273(1):309-14. PubMed ID: 7714782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958.
    Andringa G; Lubbers L; Drukarch B; Stoof JC; Cools AR
    Behav Pharmacol; 1999 Mar; 10(2):175-82. PubMed ID: 10780830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.